Monitoring compliance with Clinical Protocol and Therapeutic Guidelines for Alzheimer’s disease

Dementia is a chronic neurodegenerative disease and Alzheimer’s disease (AD) is the most prevalent type. OBJECTIVE: To describe the drug monitoring of patients enrolled in a Clinical Protocol and Therapeutic Guidelines of Alzheimer’s Disease (PCDTDA) in Brazil. METHODS: A descriptive study based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Forgerini, Marcela, Mastroianni, Patrícia de Carvalho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077856/
https://www.ncbi.nlm.nih.gov/pubmed/32206194
http://dx.doi.org/10.1590/1980-57642020dn14-010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077856/
https://www.ncbi.nlm.nih.gov/pubmed/32206194
http://dx.doi.org/10.1590/1980-57642020dn14-010004

Ejemplares similares